APA (7th ed.) Citation

GE, N., DA, S., JL, R., CD, I., SG, B., L, S., . . . CM, K. (2024). Advancing Clinical Evaluation and Treatment of Arthrogenic Muscle Inhibition: A Need for Validation and Innovation-Letter to the Editor. The American journal of sports medicine, 52(12), NP34. https://doi.org/10.1177/03635465241272410

Chicago Style (17th ed.) Citation

GE, Norte, et al. "Advancing Clinical Evaluation and Treatment of Arthrogenic Muscle Inhibition: A Need for Validation and Innovation-Letter to the Editor." The American Journal of Sports Medicine 52, no. 12 (2024): NP34. https://doi.org/10.1177/03635465241272410.

MLA (9th ed.) Citation

GE, Norte, et al. "Advancing Clinical Evaluation and Treatment of Arthrogenic Muscle Inhibition: A Need for Validation and Innovation-Letter to the Editor." The American Journal of Sports Medicine, vol. 52, no. 12, 2024, p. NP34, https://doi.org/10.1177/03635465241272410.